BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26040557)

  • 1. Analyse multiple disease subtypes and build associated gene networks using genome-wide expression profiles.
    Aibar S; Fontanillo C; Droste C; Roson-Burgo B; Campos-Laborie FJ; Hernandez-Rivas JM; De Las Rivas J
    BMC Genomics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 26040557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
    Sundaramurthy G; Eghbalnia HR
    Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marker identification and classification of cancer types using gene expression data and SIMCA.
    Bicciato S; Luchini A; Di Bello C
    Methods Inf Med; 2004; 43(1):4-8. PubMed ID: 15026826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-course gene profiling and networks in demethylated retinoblastoma cell line.
    Malusa F; Taranta M; Zaki N; Cinti C; Capobianco E
    Oncotarget; 2015 Sep; 6(27):23688-707. PubMed ID: 26143641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Path2enet: generation of human pathway-derived networks in an expression specific context.
    Droste C; De Las Rivas J
    BMC Genomics; 2016 Oct; 17(Suppl 8):731. PubMed ID: 27801297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited.
    Obulkasim A; Fornerod M; Zwaan MC; Reinhardt D; van den Heuvel-Eibrink MM
    BMC Bioinformatics; 2015 Sep; 16():305. PubMed ID: 26399969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing disease states from topological properties of transcriptional regulatory networks.
    Tuck DP; Kluger HM; Kluger Y
    BMC Bioinformatics; 2006 May; 7():236. PubMed ID: 16670008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
    Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
    Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust classification modeling on microarray data using misclassification penalized posterior.
    Soukup M; Cho H; Lee JK
    Bioinformatics; 2005 Jun; 21 Suppl 1():i423-30. PubMed ID: 15961487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level.
    Castillo D; Galvez JM; Herrera LJ; Rojas F; Valenzuela O; Caba O; Prados J; Rojas I
    PLoS One; 2019; 14(2):e0212127. PubMed ID: 30753220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
    Culhane AC; Perrière G; Higgins DG
    BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of expression patterns in the progression of disease stages by integration of transcriptomic data.
    Aibar S; Abaigar M; Campos-Laborie FJ; Sánchez-Santos JM; Hernandez-Rivas JM; De Las Rivas J
    BMC Bioinformatics; 2016 Nov; 17(Suppl 15):432. PubMed ID: 28185568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary hallmarks of the human proteome: chasing the age and coregulation of protein-coding genes.
    Lopes KP; Campos-Laborie FJ; Vialle RA; Ortega JM; De Las Rivas J
    BMC Genomics; 2016 Oct; 17(Suppl 8):725. PubMed ID: 27801289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiple kernel support vector machine scheme for feature selection and rule extraction from gene expression data of cancer tissue.
    Chen Z; Li J; Wei L
    Artif Intell Med; 2007 Oct; 41(2):161-75. PubMed ID: 17851055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.